FDA OKs Stem Cell Trial for Spinal Cord Injuries
Wed, 10/02/2013 - 1:47pm
The U.S. Food and Drug
Administration (FDA) has authorized the StemCells Inc.'s Investigational New
Drug (IND) application for clinical testing of the company's HuCNS-SC human
neural stem cells as a treatment for spinal cord injury. As a first action under
this IND, the Company is working to open U.S. sites for its Phase 1/2 clinical
trial for chronic spinal cord injury, which is currently underway in Switzerland
and Canada.http://www.dddmag.com/news/2013/10/fda-oks-stem-cell-trial-spinal-cord-injuries
No comments:
Post a Comment